ACG Clinical Guideline: Ulcerative Colitis in Adults
- PMID: 30840605
- DOI: 10.14309/ajg.0000000000000152
ACG Clinical Guideline: Ulcerative Colitis in Adults
Abstract
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, "key concept" statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.
Similar articles
-
[Management of ulcerative colitis].Ther Umsch. 2003 Mar;60(3):145-50. doi: 10.1024/0040-5930.60.3.145. Ther Umsch. 2003. PMID: 12693317 Review. German.
-
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.J Crohns Colitis. 2017 Jul 1;11(7):785-791. doi: 10.1093/ecco-jcc/jjx032. J Crohns Colitis. 2017. PMID: 28333362 Free PMC article. Clinical Trial.
-
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Gastroenterology. 2015. PMID: 25747596 Review.
-
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.N Z Med J. 2015 Oct 16;128(1423):63-76. N Z Med J. 2015. PMID: 26645757
-
Positioning Therapy for Ulcerative Colitis.Curr Gastroenterol Rep. 2015 Aug;17(8):29. doi: 10.1007/s11894-015-0454-0. Curr Gastroenterol Rep. 2015. PMID: 26143627 Review.
Cited by
-
Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis.BMJ Med. 2024 Oct 28;3(1):e000998. doi: 10.1136/bmjmed-2024-000998. eCollection 2024. BMJ Med. 2024. PMID: 39574425 Free PMC article.
-
Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.Endosc Int Open. 2024 Nov 11;12(11):E1285-E1294. doi: 10.1055/a-2437-8102. eCollection 2024 Nov. Endosc Int Open. 2024. PMID: 39534278 Free PMC article.
-
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date.Clin Exp Gastroenterol. 2024 Nov 7;17:337-345. doi: 10.2147/CEG.S391706. eCollection 2024. Clin Exp Gastroenterol. 2024. PMID: 39529660 Free PMC article. Review.
-
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials.Therap Adv Gastroenterol. 2024 Nov 7;17:17562848241293643. doi: 10.1177/17562848241293643. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39526078 Free PMC article.
-
Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss.ACG Case Rep J. 2024 Nov 6;11(11):e01544. doi: 10.14309/crj.0000000000001544. eCollection 2024 Nov. ACG Case Rep J. 2024. PMID: 39507506 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
